Transcript 1-2 mg/kg

‫مسمومیتهاي شايع داروئی‬
‫منابع‬

-1- Goldfrank’s Toxicologic Emergencies 2015

2- www.emedicine / Emergency Medicine / Toxicology
‫فراواني مسموميت ها ی دارويی‬
‫‪Mixed drug ingestion ‬‬
‫‪ ‬مواد مخدر –مواد محرک‬
‫‪ ‬ضد افسردگي سه حلقه اي‬
‫‪ ‬أنتي سايكوتيكها‬
‫‪ ‬بنزو ديازپين ها‬
‫‪ ‬بتابلوکرها‬
‫‪ ‬مسكن ها‬
 Tricyclic
antidepressant
poisoning ‫داروهاي ضد افسردگي‬
‫داروهاي ضد افسردگي‬
‫‪ ‬آ مي تريپتيلين ‪ -‬نورتريپتيلين‪...‬ما پروتيلين ‪-‬آموكساپين‬
‫>‪‬‬
‫‪1 g : Life treatening‬‬
‫)‪one pill can kill (children‬‬
‫‪‬‬
‫‪‬‬
‫‪‬‬
‫شروع عالئم سريع ) خطرناکترين لحظات ‪ 2-1‬ساعت اول پس از خوردن‬
‫تا ‪ 6‬ساعت )‬
‫تغيير وضعيت ناگهانی‬
Clinical manifestations
Delirium, Hallucination, Hypertermia, ….
Hypotension
Ventricular Tachycardia
Wide QRS (> 0.10 s)
Tricyclic Antidepressants
Symptoms

1- Midriasis ; Tachycardia

2- Coma, 3- Delirium

4- Seizures
5- Hypotension
 6- QRS > 0.1s ;
R avR >= 3 mm ; Right Axis
deviation ; Arrhythmias (VT)
 ECG is the single most important test to
determine diagnosis and prognosis

Management of TCA poisoning


1- ABCD ( Antidote)
A:Airway compromise (Artificial airway, Intubation)
B: Breathing difficulties (Oxygen, Intubation,
Mechanical ventilation)

C:Circulation Problems (IV line; ECG, Manage
hypotension, VT)

D: Drugs (Coma : Thiamine- Glucose-Naloxone –
Oxygen)
Antidote: Sodium Bicarbonate
Hypotension
Arrythmia, Wide QRS > 0.1 s, R avR  3 mm
Seizure (wide QRS)
1-2 mEq / kg bolus , Infusion (50-150 mEq / L D5W)
+
repeated bolus (ABG)
End point: Serum pH ( 7.45-7.55)
Seizure: Diazepam 0.1-0.2 mg/kg (5-10 mg),
Midazolam 0.1 mg/kg, NaHCO3
 Hyotension: N.S., NaHCO3, Norepinephrine (0.10.2 ug/kg/min), Dopamine (10-20 ug/kg/min)
 Wide QRS, R/avR>3 mm: NaHCO3
 Coma: Glucose, Naloxone, Thiamine
 Delirium: Benzodiazepines

Ventricular Arrhythmias (VT)
NaHCO3 (1-2 meq/kg) 5 min
 Lidocaine: 1-1.5 mg/kg slow IV bolus over 2-3
min
 up to 3 mg/kg total
 infusion: 1-4 mg/min IV
 IO/ET
 Monitor: ECG
 PH: 7.45-7.55

Management of TCA
Poisoning
 ABCD
, Antidote
 Gastric Lavage (GL)
 Activated Charcoal(AC)
1 g/kg, 50-100 g
 urine toxicology screen
Contraindicated medications
beta-blockers,
 calcium channel blockers,
 class IA (procainamide, quinidine,
disopyramide, moricizine),
 class IC (flecainide, propafenone),
 and possibly class III (bretylium, amiodarone,
sotalol) antidysrhythmics.

Management of TCA
Poisoning






Rapidly transport all patients with possible TCA ingestion
to the hospital because clinical deterioration often occurs
rapidly after overdose.
Supplemental oxygen and airway support (Intubation,..)
Intravenous access, Cardiac monitoring
Rapid glucose determination (finger stick)
GL + Activated charcoal
Sodium bicarbonate should be considered in life-threatening
circumstances in the pre-hospital setting.
Antipsychotics








Large toxic to therapeutic ratio
Clinical manifestations
Antichlinergic (midriasis, Tachycardia,….)
 receptor blocking (Hypotension, Miosis):Chlorpromazine
CNS (Coma, seizure,…)
Dystonic reaction (Thiotexene, halloperidol, Perphenazine,
Trifluperazine,..)
Cardiovascular (Mesoridazime, Thioridazine,
Chlorpromazine, Halloperidol)
Respiratory depression ( Coma)
Management
ABCD
‫اكسيژن‬
‫ ساكشن كردن‬+ ‫لوله گذاري داخل تراشه‬
(Counsciousness( ‫بررس ي نيازبه گلوكز‬
(Respiratory depression , pin point pupil ) ‫نالوكسان‬
Gastric Evacuation
1 g/kg ‫ دادن زغال فعال‬

Close Observation; Supportive treatment





Seizure: Diazepam 0.1-0.2 mg/kg (5-10 mg),
Midazolam 0.1 mg/kg
 Hyotension: N.S., Norepinephrine (0.1-0.2
ug/kg/min), Dopamine (10-20 ug/kg/min)
 Coma: Glucose, Naloxone, Thiamine
 Dystonic reaction: Diphenhydramine or
Biperdine or Benzodiazepine (alternative)
 Wide QRS: NaHCO3

Benzodiazepine Poisoning
 CNS
Depression (Somnolence, Stupor,
Coma), Miosis, Ataxia
 Deep
Coma, respiratory arrest (rare)
Symptoms of BZD overdose may
include the following
Dizziness
 Confusion
 Drowsiness
 Blurred vision
 Anxiety
 Agitation

Findings on physical examination
may include the following:
Nystagmus, Slurred speech
 Ataxia, Coma, Hypotonia
 Weakness, impairment of cognition
 Amnesia, Paradoxical agitation


urine toxicology screen
Managment of BZD Poisoning
ABCD
Antagonist: Flumazenil
pure BZD overdose + verbally unresponsive +no history of
long-term BZD use or seizure disorder
not recommended for use by pre-hospital personnel
Contraindication (past history of seizure, co ingestion
with drugs induced seizure e.g. TCA; BZD addiction)
 Decontamination within 1-2 h of ingestion
Gastric Lavage + Activated charcoal
Flumazenil
0.1-0.2 mg IV over 15-30 sec
 IF no response after 30 sec, administer 0.3
mg over 30 sec 1 min later


Rarely patient may require titration up to
total dose 5 mg; IF no response after 5 min,
sedation unlikely to be secondary to
benzodiazepines
Beta-Adrenergic Receptor Antagonists






In use for nearly 50 years.
treating hypertension and other cardiovascular disorders
migraine headaches,
anxiety,
and various other disorders.
As a result of their expanded use, the incidence of
overdose with these agents has also increased.
Table 1-1* B-Adrenergic Receptor Antagonist Pharmacologic Profile
Agent
Acebutolol
Atenolol
Esmolol
Metoprolol
Labetolol
Nadolol
Pindolol
Propranolol
Sotalol
Timolol
ß
Lipid
selective Solubility
yes
yes
yes
yes
No
No
No
No
No
No
low
low
low
moderate
moderate
low
moderate
High
low
moderate
Elimination Half- Life
3-4 hours
6-9 h.
10 minutes
3-4 h
5h
14-24 h
3-4 h
3-6 h
12 h
4 -5 h
Clinical Manifestations of B-Adrenergic Antagonist Toxicity
System
Manifestations
Cardiovascular
Brady cardia, conduction delays,
hypotension
Central Nervous
System
Coma, seizures
Pulmonary
Bronchospasm(unusual)
Metabolic
Acidosis, hypoglycemia, Hyperkalemia
Increased PR intervals
 Loss of atrial activity
 Atrioventricular junctional rhythm
 Widening of the QRS complex
 Atrioventricular block
 Asystole
 prolonged QT interval: sotalol overdose.
 VF, VT: uncommon (sotalol)

Diagnosis
History
 Clinical presentation
 ECG, ABG/VBG
 serum glucose and potassium levels.

Treatment end points

HR>60

SBP>90mmHg

Evidence of good organ perfusion Evidence
of good organ perfusion (improved
mentation or urine output)
Mangement

ABCD
Bradycardia
 Atropine (1 mg..>3 mg)
 Pace
Mangement (Hypotension)
Isotonic IV fluid (20 mL/kg)
 Glucagon (5-10 mg IV slow) (50-150 mcg/kg IV over 1 minute)
Infusion: 3-5 mg/hr or 50-100 mcg/kg/hr IV titrate to response
 Epinephrine for hypotension, bradycardia Unresponsive to atropine
or pacing: 2-10 mcg/min by IV infusion or 0.1-0.5 mcg/kg/min (7-35
mcg/min in 70 kg patient); titrate to response
 Calcium Chloride (1g IV central line/ over 10-20 min (emergent 5
min) slow infusion
 Insulin: 0.1-1 U/kg/h + Hypertonic glucose (10%,20,%, 50% 1 g/kg,
check BS/30min) (Dextrose infusion of 10-75 g/h may be required)
 Dopamine (5-20 ug/kg/min),Norepinephrine (0.1-0.2 ug/kg/min)

Insulin-Glucose




should be considered for overdoses that are refractory to
crystalloids, glucagon, and catecholamine infusions.
monitoring serum glucose and potassium levels
Monitoring must be conducted regularly during high-dose
insulin therapy and for up to 24 hours after its
discontinuation.
Dextrose supplementation is typically required to maintain
euglycemia


Benzodiazepines : if seizures occur.
Hemodialysis : severe cases of atenolol overdoses because atenolol is less
than 5% protein bound and 40-50% is excreted unchanged in urine.
Nadolol, sotalol, and atenolol (low lipid solubility, low protein binding)
reportedly are removed by hemodialysis. Acebutolol is dialyzable.

Consider hemodialysis or hemoperfusion only when treatment
with glucagon and other pharmacotherapy fails.

Cardiac pacing: Cardiac pacing may be effective in increasing the rate of
myocardial contraction.
 cardiac pacing for patients unresponsive to pharmacologic therapy
torsade de pointes unresponsive to magnesium
 Resuscitation should be
aggressive and prolonged.





Gastric lavage may be beneficial if the patient presents
to the ED within 1-2 hours of ingestion.
Activated charcoal
Although most useful if used within 4 h of ingestion,
repeated doses may be used, especially with ingestions
of sustained-released agents.
Adult:1 g/kg PO up to 50-100 g
Pediatric: 1-2 g/kg PO , up to 15-30 g
35
‫با تشكر‬
Glucagon can enhance myocardial
contractility, heart rate, and atrioventricular
conduction;
 Load: 50-150 mcg/kg IV over 1 minute,
THEN
 3-5 mg/hr or 50-100 mcg/kg/hr IV; titrate
infusion to achieve adequate clinical response

Dopamine
5-15 mcg/kg/min IV (medium dose): May increase
heart rate, and cardiac contractitlity
 20-50 mcg/kg/min IV (high dose): May increase
blood pressure and stimulate vasoconstriction;
may not have a beneficial effect in blood pressure;
may increase risk of tachyarrhythmias
 May increase infusion by 1-4 mcg/kg/min at 10-30
min intervals until optimum response obtained
 Titrate to desired response

calcium
Beta-blocker Overdose, Refractory to
Glucagon & High Dose Vasopressor
 Calcium chloride 1000 mg IV bolus via
central line over 10-20 min (emergent 5
min)

Insulin-Glucose

The currently recommended regimen is a 1
U/kg of an insulin bolus followed by
continuous infusion of 1-10 U/kg/h, but
boluses of up to 10 U/kg and continuous
infusions as high as 22 U/kg/h have been
used with good outcomes and minimal
adverse events. Dextrose infusion of 10-75
g/h may be require
Acetaminophen

Commonest drug used
DANGEROUS , PEOPLE DON’T KNOW IT
YOU FEEL WELL AND THEN THE LIVER
FAILURE SETS IN..
 NAPQI (TOXIC mtetabolite)
 Glutathione
 Toxic dose: 7.5 g , 150 mg/kg

Acetaminophen poisoning
Phase 1 (0-24 h)
Asymptomatic
Anorexia, Nausea or vomiting, Malaise
serum transaminases levels 12 hours postingestion
Phase 2 (18-72 h)
Right upper quadrant abdominal pain, anorexia, nausea,
vomiting, rise in serum transaminases
Phase 3 (72-96 h)
Hepatic necrosis with continued abdominal pain, Jaundice ,
Coagulopathy, Hepatic encephalopathy, Renal failure, Fatality
Phase 4 (4 d to 3 wk)
Complete resolution of symptoms (7-10 days), or death,
Complete heaptic recovery (3-6 months)
Acetaminophen ingestion should be
considered as a potential cause of illness in
patients who present with hepatic
dysfunction of unknown etiology.
 Acetaminophen crosses the placenta, and
the fetal liver is able to elaborate NAPQI by
14 weeks of gestation. A delay in treating
pregnant patients with antidotal therapy is
associated with fetal demise.

Acetaminophen Overdosemanagement







ABCD ( usually well systemically)
Gastric lavage, Activated charcoal
Antidote: N-Acetylcysteine, IV (20 h)
Shown to be advantageous if given in the first 8
hours
Early administration of NAC, within 8 hours of
ingestion, is nearly 100% hepatoprotective
NAC should be administered if the patient
presents close to or later than 8 hours after an
acute ingestion or if the patient is pregnant.
Follow up
‫ارگانو فسفره‬
‫‪‬‬
‫‪‬‬
‫‪‬‬
‫موارد استفا د ه‬
‫براي از بين بردن حشرات در كشاورزي‬
‫پاراتيون ؛ ديازينون ؛ ماالتيون‬
‫‪‬‬
‫‪‬‬
‫‪‬‬
‫بعنوان گازهاي جنگي‬
‫گاز جنگي سارين ؛ سومان‬
‫فارماكو كينتيك‬
‫‪ ‬جذب ‪ :‬گوارشي ؛ پو ستي ؛ تنفسي ؛‬
‫چشمي‬
‫‪‬‬
‫متابوليسم ‪ :‬كبد‬
‫‪‬‬
‫دفع ‪ :‬دفع متابوليتها از طريق ادرار‬
‫‪ ‬نيمه عمر دفعي ‪ 2/89 :‬ساعت در‬
‫ماالتيون و ‪ 1/2‬روز در متيل پاراتيون‬
‫مكانيسم اثر‬
‫‪ ‬مهار كننده غير قابل برگشت‬
‫آنزيم كلين استراز‬
‫‪‬‬
‫‪‬‬
‫شروع عال ئم ‪ :‬در طي چند دقيقه تا چند‬
‫ساعت‬
‫‪ -1‬عالئم موسكاريني‬
‫‪ ‬افزايش ترشح بزاق (سيالوره)‪ ،‬اشكريزش‬
‫‪ ‬ابريزش از بيني‬
‫‪ ‬تعريق‬
‫‪ ‬ميوز‬
‫‪ ‬اسهال‪ ،‬درد شکمی‬
‫‪ ‬بی اختياری ادرار و مدفوع‬
‫‪ ‬برادي كاردي ؛ هيپو تانسيون‬
‫‪ -2‬عالئم نيكوتيني‬
‫‪ ‬ضعف‬
‫‪ ‬فاسيكوالسيون………‪.‬فلج عضالت‬
‫‪ ‬تاكيكاردي‬
‫‪ ‬هيپر تانسيون‬
‫‪ ‬ميدرياز‬
‫‪ -3‬عال ئم سيستم عصبي‬
‫مركزي‬
‫‪‬‬
‫‪‬‬
‫‪‬‬
‫‪‬‬
‫‪‬‬
‫اضطراب‬
‫گيجي‬
‫كما‬
‫تشنج‬
‫دپرسيون مركز تنفس و قلبي‬
‫‪ABCD ‬‬
‫‪ ‬لوله گذاري داخل تراشه در صورت ترشحات فراوان‬
‫‪ ‬اكسيژن‬
‫‪ ‬آنتي دوتها ‪:‬‬
‫‪ -1 ‬آتروپين ‪ :‬باعث از بين رفتن عالئم موسكاريني و سيستم‬
‫عصبي مركزي مي شود ‪.‬‬
‫‪ ‬آتروپين تا زماني داده ميسود كه ترشحات خشك شوند و يا‬
‫عال ئم مسموميت با آتروپين ظاهر شود‪.‬‬
‫‪ -2 ‬پراليدوكسيم‬
Management of OPs Poisoning






ABCD (Intubation, Suctioning , Oxygen, MV)
Antidotes:
Atropine (Adult 1-2 mg IV, repeat every 1-5 min.
Children, 0.01 mg/kg
Infusion 0.02-0.08mg / kg/h (depends on patient)
Pralidoxime :Adult 1-2 g / 200 cc Normal saline IV/30
min
Continued infusion Up to 500 mg / h
Gastric Lavage + Activated charcoal + Dermal
Decontamination
Opioid
poisoning
‫مواد مخدر‬
‫‪ ‬ترياك‬
‫‪ ‬هروئين‬
‫‪ ‬بوپرنورفین‬
‫‪ ‬متادون‬
‫‪ ‬ترامادول‬
‫‪ ‬ديفنوکسیالت‬
Pharmacokinetics
1- GI tract : Methadone,
Diphenoxylate,
Opium
Peak effects generally are
bioavailability :60-79% : methadone
IV, Inhalation: 1-5 minutes (Heroin)
2. Nasal mucosa: Heroin
Nasal insufflation: 10-15 minutes (Heroin)
3. IV, Inhalation, smoking Heroin
PO: 90 minutes
4. Rectal mucosal
Methadone (Dolophine)
excellent oral bioavailability (to 100%).
 Metabolism: 90% metabolized in the liver and intestines
……>
excreted almost exclusively in feces
 ( an advantage in patients with renal insufficiency or
failure), <10% unchanged
 High lipid solubility, it is redistributed to the fat tissues,
and has a very long elimination phase, with a half-life of
up to 150 hours.
Methadone (Dolophine)
The metabolism of methadone is always variable.
Methadone is metabolized by CYP3A4 primarily and
CYP2D6 secondarily;


CYP3A4 expression can vary up to 30-fold, and there can
be genetic polymorphism of CYP2D6, ranging from poor to
rapid metabolism.
Methadone (Dolophine)




its analgesic action (4-8 hours) is significantly
shorter than its elimination half-life (up to 150
hours),
and patient self-directed re-dosing and a long
half-life may lead to the potential of respiratory
depression and death.
lack of awareness of its metabolism
its long half-life…….> increase in the deaths
associated with this medication.




Risk of Torsades de Pointes, a potentially fatal
arrhythmia,
Congenital QT prolongation,
high methadone levels (usually over 200 mg per
day),
conditions that increase QT prolongation
(hypokalemia and hypomagnesemia)
Pharmacokinetics
A single day’s maintenance dose in a
tolerant dult can cause life-threatening
respiratory depression in an adult who
is not tolerant, and as little as 10 mg
can be fatal in a child.
Tramadol (Ultram)
absorbed rapidly
 one fifth to one tenth as potent as morphine.
max dose: 400 mg/24 hrs




decrease dose in elderly & renal impaired
May enhance risk of seizures
Caution should be exercised when combining tramadol
with MAOIs, neuroleptic agents, and other drugs that
lower the seizure threshold.
Heroin Adulterants
When heroin first enters the U.S., it may be 95%
pure, by the time it is sold, it is 3 to 5% pure.
 Heroin combined with cocaine is called
“speedballing.”
 Iran heroin has strychnine, Lactose, mannitol,
quinine, Talcum powder, starch, curry powder
 Other adulterants: Caffeine, Acetaminophen,
Phenobarbital, …

IVDU related infections


Botulism: Subcutaneous or IM administrations (26 case
of botulism in California; impure form of heroin : black
tar heroin)
Tetanus: users of quinine-adulterant heroin more likely
to develop tetanus than no-quinine-adulterant heroin
(extensive tissue destruction by SC or IM quinine)
IVDU related infections
Hepatitis B & C
 HIV
 Malaria
 American trypanosomiasis (Chagas disease)
 Leishmaniasis (Spanish IVDU)
 Syphilis

Non viral infections






Usually staphylococci (75%) and/or streptococci
from skin
Anaerobes from mouth
Faecal organisms from groin area
Fungi from lemon juice
Contaminants from drugs
Anaerobes with muscle popping
Murphy EL et al. J Inf Dis 2001; 33: 35-40
Bassetti S, Battegay M. Infection 2004; 32: 163-9
Generalised infections
Bacteraemia (septicaemia)
 Pneumonia & lung abscess
 Endocarditis (heart valves)
 Other deep abscesses
 Septic arthritis
 Osteomyelitis
 etc

NEUROLOGICAL COMPLICATIONS
Coma without complications
Hypercapnia, hypoxia, cardiorespiratory arrest
Most recover & discharged
Coma with neurological sequelae
-Seizures
-Acute delirium
-Delayed post anoxic encephalopathy (residual
weakness, cognitive impairment, spasticity)
-Involuntary movement disorder (Parkinsonism,
dystonias)
Deaf ness
NEUROLOGICAL COMPLICATIONS
Brain edema,
myelin damage,
astrocytic, globus pallidus cysts
reduced neuronal populations.
Diagnosis
(1)
hypoxia
1- history
2- clinical
presentation
(2)
early stages
of Lomotil poisoning when the atropine
* specific toxidromes
1- decreased
respiratory rate,
effects
predominate
a. miosis
cyanosis,
 (3) after the
b. Apnea,
CNSof
depression
use
naloxone
2- hypoxia
on pulse
oximetry,
 c. respiration
depression
most opioid-related
deaths, the most specific
(4)potentially
after the use
of a co-ingestant
sign 3- hypercarbia
or hypoxia
on
* Noncardiogenic pulmonary
edema (NCPE) (Heroin,
cyclic antidepressants).
Mydriasis (sympathomimetics,
ABG.
methadone) (Tachycardia, Tachypnea, …)(CXR)
3- screening technique :
* qualitative(urine)
Positive results are observed up to 36-48 hours post-exposure, but wide
variations are possible depending upon test sensitivity, dose, route, and
the patient's metabolism.
Management
General Mx

Specific Mx
Aggressive airway management
 use of Naloxone
are the mainstay of therapy.
Naloxone









Life threatening (cyanosis):
1- Respiratory support: Oxygen, Bag-vlave-mask, positioning,
suctioning
2- Naloxone: 0.4-2 mg (IV, IT, SC, IM, IL, SL)..…………….>
Correct respiratory depression
Intubation and ventilation
Children: 0.1 mg kg
Non life threatening: (RR < 14 without cyanosis or res. Arrest,..)
Respiratory support: Oxygen, Bag-vlave-mask
Addict: Initial 0.05 mg…> Correct respiratory depression
Non-addict: 0.4 mg….> Correct respiratory depression








Altered mental status: Glucose [0.5-1 g/kg (DW
50% in adult, 20% children, 10% neonate)]
Thiamine
ICU, pulseoxymetery, ABG or VBG
Wards: Close observation (Parents or friends,….)
Gastric evacuation (kind, route, time,..)
Activated charcoal : 1 g /kg
Body packers:
Whole bowel irrigation (poly ethelene glycole)
Multiple dose of AC :
Non-cardiogenic pulmonary edema
Heroin, Methadone
 Tachypnea, tachycardia, .....
 Intubation + ventilation (PEEP)

Dx and Treat
1-3 min onset of action
5-10ofmin
max effects
Indications
ENDOTRACHEAL
1- long-acting
10-30
minopiates
half-life
INTUBATION:
(methadone30-90
,diphenoxylate,…)
min duration
of
if there
is
no
response
to
the
Naloxone
action 2-Recurrent Res. Dep
3-Large
initial
dose of Naloxone
Route of
administration
:
4-Body-packer
IV ,IM ,SC ,ET ,IL ,SL
5-Suicidal attempt Ingestion (consider addiction)
6-Children
7-Low Staff support
Treatment
DRUG ABUSE
Drugs

Drugs refer to a non food substance that is
deliberately taken to produce some
physiological or psychological effect
Stimulants

Amphetamines

Quickly develop a tolerance
Found in diet pills
Students, truck drivers use them to stay awake
When the drug wears off you suddenly fall
asleep
Avoid the experimental stage and use it for a
specific reason which increases the chance for
addiction
Depression occurs during withdrawal
Must deal with psychological addiction




Acute overdose of amphetamines






Central nervous system
 Change of mental status, disorientation, and headache, Dyskinesias,
Agitation, Stroke
Cardiovascular
 Chest pain, Palpitations
Gastrointestinal
 Dry mouth, Nausea and vomiting, Diarrhea
Genitourinary - Difficult micturition
Skin/cutaneous
 Diaphoresis, Erythematous painful rashes, needle marks, Infected deep
ulcerations (ecthyma)
Ocular - Mydriasis
Seizures, hypertension, tachycardia, hyperthermia, psychosis,
hallucinosis, stroke, and fatality
Stimulants

Methamphetamines

Ice, crystal
Euphoria, stimulant, and anorectic effects
Effects felt in first 7 seconds after smoked, injected, pills
or snort Effects last several hours
The euphoria produced by methamphetamine appears
similar to that produced by cocaine.
taken orally, IV, or smokable form
Patients who inhale the smokable form of
methamphetamine (ice): immediate euphoria similar to
that of crack cocaine, but the effects may last much
longer.





Methamphetamines

synthesis from inexpensive and readily obtainable chemicals
has led to the widespread increase in abuse of this dangerous
drug.

Methamphetamine lacks much of the peripheral stimulant properties
of amphetamine while still offering euphoric and hallucinogenic
properties.
These actions are similar to those of cocaine; however, while effects of
cocaine last for 10-20 minutes, duration of amphetamine action is much
longer, lasting as long as 10-12 hours.
Chronic use: Wt loss, Psychological addiction (Withdrawal
see fatigue, depression), Infections
Stimulants

Cocaine



Can be




Originally : relieve fatigue
Very addictive
Snorted
Injected
Ingestion
Effects do not last long

Repeat dose in 5-30 min especially for heavy users
Cocaine enters the United States in the form of a hydrochloride salt







Crack is produced when the hydrochloride molecule is commonly
removed by ether extraction, which frees the basic cocaine molecule, the socalled freebase.
Heating does not destroy freebase, these are physical properties that allow it
to be smoked.
Crack is lipid soluble and therefore rapidly absorbed in the pulmonary
capillaries.
The term crack characterizes the crackling sound heard when cocaine
freebase is smoked.
Crack may be smoked in a pipe bowl or in a cigarette
Smoking crack bypasses the vasoconstriction that results when cocaine is
snorted; therefore, the effects are similar to taking cocaine IV.
Crack smokers may aggressively inhale against a small pipe and then
perform a Valsalva maneuver before exhaling against pursed lips or
forcefully blow the drug into a partner's mouth. These techniques are reputed
to enhance the euphoria of cocaine.
Cocaine / Crack
Absorbs from mucous mbr, IV
 Onset 1-2 minutes, ½ life = 60 min
 passive inhal./breast milk  seizure
  blocks reuptake of neurotransmitters on
presyn, nerves (Accumulation of Epi, Nor,
Dopa, Serot)
  and is a fast Na channel blocker (prolongs
QRS)

Cocaine / Crack, Clinical
CNS: mood elevation, hallucination, tremor,
hyper , mydriasis, Seizures
 Resp.CV: Hypertension, ACS (Acute Coronary
Syndrome)  02 demand, coronary artery const.
Myocardial infarction, chest pain. Prolonged
QRS, QT, VT, VF
 Platelets: Aggregation, activation


Cocaine and Alcohol
 become
the most common combination
 forms a metabolite, Cocaethylene, which is
less potent than cocaine but has longer half
life (3-5X longer)
 risk of sudden death increases to as high as
20 times than with cocaine use alone
Stimulants
Crack/ cocaine
 Very addictive
 Combines cocaine with baking soda and heated
in a pipe and vapors inhaled into the lungs
 May be combined with heroin or
methamphetamine and given IV a speedball
 In both cases, the second drug is used to
supplement, rather than substitute, the
primary drug.

Cocaine / Crack Treatment
ECG monit (troponin)
 Benzodiazepine (no
phenothiazine)
 “MONA” greets all
patients: Morphine, O2,
Nitroglycerin
0.2 – 0.5 mcg/kg/min




ASA / Heparin
Na H CO3 1 – 2 mcg/Kg
No ß-blocker (antagonize
cocaine ß adrenergic
stimulation and
vasodilation)
Ecstasy
MDMA (ecstasy, XTC, Adam, E, X,
clarity, Stacy)





MDMA is available as a tablet, capsule, powder, and
liquid; most commonly is used in tablet form
Dancing Tablet
Each tablet contains 50-100 mg of MDMA ($20-25)
Effective doses: 1-2 mg/kg (initial effects in 30-60 min,
Peak effects at 90 minutes and may persist 4-8 h)
Severe hyperthermia has been reported at doses of 4-5
mg/kg





Central nervous system
 Change in mental status, seizures, Anxiety, paranoia,
Increased psychomotor activity, restlessness,
Hyperthermia, hot flashes, Headache, Ataxia, Blurred
vision, halos, Syncope
Cardiovascular
 Palpitations , Chest pain
Gastrointestinal
Dry mouth, Nausea, vomiting, Abdominal cramping, Anorexia
Skin
 Diaphoresis, Piloerection
Urinary retention, difficulty voiding, Sexual dysfunction








ABCs: ETI and MV (seizures, cardiovascular instability, or trauma) (oxygen,
IV access, cardiac monitoring)
A bedside glucose determination (altered mental status)
Place the patient in a calm quiet room
Agitation or disruptive behavior: benzodiazepines and/or physical restraints
acute toxicity by ingestion (GID + activated charcoal)
Whole bowel irrigation (body packing of drugs is suspected)
Severe hyperthermia (aggressive cooling measures and adequate fluids)
Obtain a rectal temperature. Morbidity is directly related to the severity and
duration of hyperthermia.
 Undress the patient.
 Apply evaporative cooling with water and a fan.
 Apply ice packs to the groin and axilla.
 Iced gastric lavage may be considered.
 Control shivering with a benzodiazepine.
 Antipyretics are not useful.
Hypertension: benzodiazepine
 refractory symptoms or signs of end-organ
damage, (nitroprusside or nitroglycerin)
 Pregnancy testing in patients with overdose.
MDMA, like all amphetamines, can be
toxic to the fetus and may induce
miscarriage or premature labor

Ecstasy
Parkinsonian symptoms, shaking with movement
 chronic depression
 Strong psychological addiction

Marijuana






5000 year old history
Used as a pain reliever before aspirin
Euphoria, heightened sensory experience
THC active ingredient, fat soluble and may
stay in body tissue for a month
High probability of psychological dependence,
low probability of physical dependence
Used for glaucoma, chemotherapy and AIDS
patients
Marijuana

Long term effects





Chronic bronchitis and damage to lungs
Lung cancer
Lower testosterone levels and abnormalities in
sperm count
Alters menstrual cycle, low birth weight infants
Damages the immune system
‫با تشكر‬
Nalterexone
*latency to onset (oral tablet 15-30 min.)
*duration of action 24-72 hours
*peak effect (6-12 hours)
opioid receptor antagonist. It is longer acting than
naloxone
Plasma half-life of 8 to 12 hours versus 0.5 to 1.5 hours,
Naltrexone, like naloxone, can stimulate the
cardiovascular system.